Test Price
2,800 AED✅ Home Collection Available
SPTLC1 Gene HSAN1 Genetic Test in UAE | 2,800 AED | DHA-Approved NGS Analysis
Executive Summary & Core Metrics
Executive Summary: Highly accurate genetic screening for hereditary sensory and autonomic neuropathy type 1 (HSAN1) using next‑generation sequencing, compliant with Dubai Health Authority guidelines. Includes ISO‑certified cold‑chain home collection and post‑test telephonic consultation.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary Telephonic Post‑Test Clinical Guidance for result interpretation and next‑step counselling.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The SPTLC1 Gene HSAN1 Genetic Test uses next‑generation sequencing (NGS) to detect pathogenic variants in the SPTLC1 gene, confirming hereditary sensory and autonomic neuropathy type 1. This single‑gene analysis, performed on peripheral whole blood, extracted DNA, or FTA card, provides definitive molecular diagnosis crucial for clinical management and family risk assessment.
| Feature | Our Test (SPTLC1 NGS) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (Illumina platform) | Sanger Sequencing (single‑exon focus) |
| Variant Detection | Full gene coding region, including deep intronic & regulatory variants | Limited to selected exons; may miss large deletions |
| Diagnostic Sensitivity | 99.9% (ISO‑verified analytical sensitivity) | ~85% in typical settings |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Report Detail | ClinVar‑linked, ACMG classification, inheritance risk | Basic pathogenic/benign call |
| Regulatory Alignment | DHA & MOHAP approved, ISO 9001:2015 | No recent DHA re‑accreditation |
Physician Insight & Safety Protocols
“I understand the uncertainty that comes with potential hereditary neuropathy—this test can finally bring answers, but it must be interpreted alongside your clinical examination and full family pedigree. Please make use of the post‑test telephonic consultation we offer; it’s designed to guide your next steps safely and empathetically.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA License: 9294403
⚠️ Medication Advisory
Do not discontinue any prescribed medication without consulting your treating physician. This genetic test does not replace ongoing clinical care.
Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Inability to provide informed consent; minors without legal guardian consent; active bloodborne infection that precludes safe phlebotomy (home collection team will pre‑screen).
- ER Red Flags: If you experience sudden foot drop, breathing difficulty, loss of bladder control, or severe unexplained pain before your results, visit an emergency department immediately—do not wait for the genetic report.
Patient FAQ & Clinical Guidance
1. What does a positive SPTLC1 mutation mean for my health?
A: A positive SPTLC1 mutation confirms hereditary sensory and autonomic neuropathy type 1, a progressive disorder with sensory loss and autonomic dysfunction. Early diagnosis enables targeted surveillance, pain management, and genetic counselling for family members.
2. Why does the test take 3–4 weeks?
A: Next‑generation sequencing involves DNA extraction, library preparation, high‑depth sequencing and rigorous bioinformatics analysis, ensuring 99.9% diagnostic accuracy. Each step follows ISO 9001:2015 quality controls, which extends turnaround time but guarantees reliable results.
3. Is home sample collection safe and DHA‑approved?
A: Yes, our DHA‑licensed phlebotomists perform home sample collection using ISO‑certified cold‑chain transport and infection control, available 8 AM–11 PM across all UAE Emirates. The service complies with UAE Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning use of ICT in health fields.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This service adheres to UAE Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled with strict confidentiality and access controls.
Accreditation: ISO 9001:2015 Quality Management System (Cert: INT/EGQ/2509DA/3139).
Pre‑requisite: A genetic counselling session to draw a detailed family pedigree is mandatory before sample collection. Contact us to schedule this session.
Clinical & Logistical Metadata
| Test Name | SPTLC1 Gene HSAN1 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood, extracted DNA, or FTA card (non‑invasive home collection available) |
| Methodology Used | Next‑Generation Sequencing (Illumina platform) |
| ICD-10-CM Code | G60.8 |
| LOINC Code | 94216-8 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians